First human test of new hope for Tough-to-Treat blood cancer
NCT ID NCT07409246
Summary
This is the first study in people to test a new drug called ABBV-438 for advanced multiple myeloma, a blood cancer that has returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body processes the drug. About 127 adults worldwide who have already tried at least three other types of therapy will receive the drug by IV infusion to help researchers learn if it is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.